Ajooni Biotech

Ajooni Biotech Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Ajooni Biotech (AJOONI.NS) as of Oct 19, 2026 is -0.75. In the previous year, Net Debt to Free Cash Flow Ratio was 0.25 — a change of -401.79% (lower).

Net Debt/FCF

-0.75

YoY

-401.79%

Last updated:

Net Debt to Free Cash Flow Ratio of Ajooni Biotech is 2026 -0.75 . Net Debt to Free Cash Flow Ratio of Ajooni Biotech was 2025 0.25 . It decreases by -401.79% lower compared to the previous year.

The Ajooni Biotech Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2019
-0.01 INR
Jan 1, 2020
-0.85 INR
Jan 1, 2021
-2.76 INR
Jan 1, 2022
3.39 INR
Jan 1, 2023
-0.55 INR
Jan 1, 2024
-0.18 INR
Jan 1, 2025
0.25 INR
Jan 1, 2026
-0.75 INR
The Ajooni Biotech Net Debt/FCF history
YEARNet Debt/FCFYoY
-0.75-401.79%
0.25-236.04%
-0.18-67.23%
-0.55-116.35%
3.39-223.05%
-2.76+225.53%
-0.85+10,642.97%
-0.01-100.36%
2.18-174.00%
-2.94+224.78%
-0.91—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ajooni Biotech Stock analysis

What does Ajooni Biotech do? Ajooni Biotech Ltd, listed on the National Stock Exchange of India with ticker AJOONI.NS and ISIN INE820Y01021, is a company operating in the Consumer Staples sector, specifically within the Food Products industry. Headquartered in Mohali, Punjab, the company went public through an IPO on January 2, 2018. Ajooni Biotech focuses on the manufacturing, production, processing, and supply of cattle feed nutrients and animal health care supplements. The company offers a variety of products including compounded animal feed and feed supplements designed to support the entire life cycle of animals. Its product range encompasses cattle feed, cattle feed chips, camel feed, cotton oil cake, and mustard oil cake. The firm provides high-energy balanced cattle feed formulations such as calf starter, heifer, dairy calf grower, low yield cattle, basic milking cattle, and high yield cattle feeds. Specific product names mentioned include Autus DIAMOND WONDER, Autus NURTURE CALF STARTER, Autus WINNER, Autus HIFFER/GROWER, Autus ENERGY PLUS, Autus ECO, and Autus BUFF POWER. Additionally, the company supplies feed supplements like liquid calcium, liver tonic, mineral mixture, ultra-tonic, digestive powder, and multi vitamins, as well as products such as CALTUS, 4U, LIVTUS, RUMITUS, Mustmin, and AUTOVITA. The company's website is https://www.ajoonibiotech.com/. Ajooni Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ajooni Biotech stock

Net Debt to Free Cash Flow Ratio of Ajooni Biotech is -0.75 in 2026.

Net Debt to Free Cash Flow Ratio of Ajooni Biotech changed from 0.25 to -0.75, representing a -401.79% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Ajooni Biotech since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Ajooni Biotech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Ajooni Biotech

All Key Metrics — Ajooni Biotech